NeuroBionics

NeuroBionics is pioneering a new class of minimally invasive neuromodulation technologies that deliver deep brain and peripheral nerve stimulation without open surgery. Using hair-thin, catheter-delivered bioelectronic fibers that navigate blood vessels smaller than 2mm, the system can precisely target deep neural circuits while reducing procedural risks and recovery times. Backed by over a decade of MIT research, multiple patents, and validated preclinical studies, NeuroBionics’ platform expands access to therapies for conditions such as stroke, epilepsy, Parkinson’s disease, and chronic pain. The venture is initially targeting the peripheral vagus nerve stimulation, before expanding to brain applications such as stroke rehabilitation. Its ultra-flexible, removable design makes neuromodulation safer, faster, and more broadly accessible, advancing the future of precision bioelectronic medicine.